Insights from 2023 IMS Annual Meeting

 

Insights from 2023 IMS Annual Meeting
F

IMS 2023 Insights: "Serial MRD Assessments as a Surrogate for Long Term PFS in Myeloma"

By Insights from 2023 IMS Annual Meeting FEATURING Frits van Rhee
By Insights from 2023 IMS Annual Meeting FEATURING Frits van Rhee
0 views
October 19, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Videos
18:30
Insights from 2023 IMS Annual Meeting

ASH 2023 Insights: "Emapalumab for Treatment of Impending Graft…

Feat. A. Sabulski
05:08
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Applicability of the R2-ISS Staging System …

Feat. J. Bila
13:18
Insights from 2023 IMS Annual Meeting

Highlights and Key Takeaways From the 2023 International Myeloma Soc…

Feat. A. Jakubowiak
05:53
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Post-Induction Undetectable Flow MRD Amelio…

Feat. G. Seval
08:48
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Isa-KRd in High-Risk NDMM - Planned Interim…

Feat. L. Leypoldt
09:00
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Time to Tailor? Treatment Selection at Firs…

Feat. M. Delforge
10:33
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Early Outcomes & Therapy Modification S…

Feat. S. Kumar
07:22
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Time for T? Expanding Treatment Paradigms i…

Feat. R. Mina
06:17
Oncology Data Advisor

Linvoseltamab for R/R MM: LINKER-MM1 Trial Results From IMS 2023

Feat. M. Dhodapkar
10:13
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Serial MRD Assessments as a Surrogate for L…

Feat. F. van Rhee
16:07
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "What Is the Ideal Duration of Treatment in …

Feat. K. Yong
09:19
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Optimizing Supportive Care Management in Ne…

Feat. E. Terpos
13:32
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Second Primary Malignancies After Tandem aH…

Feat. S. Al Hadidi
11:31
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Epigenetic Drivers of Disease Progression i…

Feat. F. Prosper
03:17
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Highlights From the International Myeloma S…

Feat. J. Richter
22:17
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Unraveling the Myeloma Proteome"

Feat. A. Wiita
09:52
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Epigenetic Regulation of CD38/48 by KDM6A a…

Feat. J. Liu
07:11
Insights from 2023 IMS Annual Meeting

IMS 2023 Insights: "Final Survival Outcomes From the Ph3 OPTIMI…

Feat. M. Beksaç